Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/30/21 → 8/31/23 |
Funding
- Ridgeline Therapeutics: $353,863.00
Preclinical Developments of a Novel Therapeutic to Rejuvenate Aging Muscle Stem Cells and Enhance Muscle Strength and Function Post Hip Fracture
- Fry, Christopher (PI)